The role of progestogen supplementation (dydrogesterone) in the prevention of preeclampsia

References

• Mayrink J, Costa ML, Cecatti JG. Preeclampsia in 2018: revisiting concepts, physiopathology, and prediction. Sci World J. 2018;2018:1–9.
   Google Scholar
• Rana S, Lemoine E, Granger J, et al. Preeclampsia. Circ Res. 2019;124(7):1094–1112.
   PubMed Web of Science ®Google Scholar
• Dymara-Konopka W, Laskowska M, Oleszczuk J. Preeclampsia - current management and future approach. Curr Pharm Biotechnol. 2018;19(10):786–796.
   PubMed Web of Science ®Google Scholar
• Wright D, Syngelaki A, Akolekar R, et al. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am J Obstet Gynecol. 2015;213(1):62–62.e10. Jule1-
   PubMed Web of Science ®Google Scholar
• O’Gorman N, Wright D, Syngelaki A, et al. Competing risks model in screening for preeclampsia by maternalfactors and biomarkers at 11-13 weeks gestation. Am J Obstet Gynecol. 2016;214(1):103–103.e12.
   PubMed Web of Science ®Google Scholar
• Francisco C, Wright D, Benkő Z, et al. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternalfactors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol. 2017;50(5):589–595.
   PubMed Web of Science ®Google Scholar
• Tolcher MC, Chu DM, Hollier LM, et al. Impact of USPSTF recommendations for aspirin for prevention of recurrent preeclampsia. Am J Obstet Gynecol. 2017;217(3):365.e1–365.e8.
   Web of Science ®Google Scholar
• Wright D, Poon LC, Rolnik DL, et al. Aspirin for evidence-based preeclampsia prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia. Am J Obstet Gynecol. 2017;217(6):685.e1–685.e5.
   PubMed Web of Science ®Google Scholar
• Poon LC, Wright D, Rolnik DL, et al. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Am J Obstet Gynecol. 2017;217(5):585.e1–585.e5.
   PubMed Web of Science ®Google Scholar
• Hofmeyr GJ, Lawrie TA, Atallah AN, et al. Calciumsupplementation during pregnancy for preventing hypertensive disorders and relatedproblems. Cochrane Database Syst Rev. 2014;24(6):CD001059.
   Google Scholar
• Hofmeyr GJ, Lawrie TA, Atallah ÁN, et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2018;110:CD001059.
   PubMedGoogle Scholar
• Zhao X, Fang R, Yu R, et al. Maternal vitamin D status in the late second trimester and the risk of severe preeclampsia in Southeastern China. Nutrients. 2017;9(2):138.
   Web of Science ®Google Scholar
• Pashapour S, Golmohammadlou S, Behroozi-Lak T, et al. Relationship between low maternal vitamin D status and the risk of severe preeclampsia: a case control study. Pregnancy Hypertens. 2019;15:161–165.
   PubMed Web of Science ®Google Scholar
• Zhuang C, Gao J, Liu J, et al. Risk factors and potential protective factors of pregnancy-induced hypertension in China: a cross-sectional study. J Clin Hypertens. 2019;21(5):618–623.
   Web of Science ®Google Scholar
• Yabes-Almirante C. Calcium supplementation in pregnancy to prevent pregnancy induced hypertension (PIH). J Perinat Med. 1998;26(5):347–353.
   PubMed Web of Science ®Google Scholar
• Labarrere CA, DiCarlo HL, Bammerlin E, et al. Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta. Am J Obstet Gynecol. 2017;216(3):287–287.e16.
   PubMed Web of Science ®Google Scholar
• Sammour MB, el-Kabarity H, Fawzy MM, et al. Prevention and treatment of pregnancy-induced hypertension (preeclampsia) with progestogens. J Steroid Biochem Mol Biol. 2005;97(5):439–440.
   PubMed Web of Science ®Google Scholar
• Ali AB, Ahmad MF, Kwang NB, et al. Dydrogesterone support following assisted reproductive technique (ART) reduces the risk of pre-eclampsia. Horm Mol Biol Clin Investig. 2016;27(3):93–96.
   PubMed Web of Science ®Google Scholar
• Schindler AE. New data about preeclampsia: some possibilities of prevention. Gynecol Endocrinol. 2018;34(8):636–637.
   PubMed Web of Science ®Google Scholar
• Schindler AE. Present and future aspects of dydrogesterone in prevention or treatment of pregnancy disorders: an outlook. Horm Mol Biol Clin Investig. 2016;27(2):49–53.
   PubMed Web of Science ®Google Scholar
• Schindler AE. Progestogens for treatment and prevention of pregnancy disorders. Horm Mol Biol Clin Investig. 2010;3(3):453–460.
   PubMedGoogle Scholar
• Tskhay VB, Kovtun NM, Schindler AE. Successful prevention of preeclampsia in a high-risk pregnancy using progestogen dydrogesterone: a clinical case. Horm Mol Biol Clin Investig. 2016;27(3):85–88.
   PubMed Web of Science ®Google Scholar
• Wu JL, Jia J, He MZ, et al. Placental origins of preeclampsia: potential therapeutic targets. Curr Med Sci. 2019;39(2):190–195.
   PubMed Web of Science ®Google Scholar
• Cerdeira AS, Agrawal S, Staff AC, et al. Angiogenic factors: potential to change clinical practice in preeclampsia? BJOG. 2018;125(11):1389–1395.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Chattopadhyay R, Goswami S, et al. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study. J Obstet Gynaecol Res. 2014;40(7):1871–1876.
   PubMed Web of Science ®Google Scholar
• Zainul Rashid MR, Lim JF, Nawawi NH, et al. A pilot study to determine whether progestogen supplementation using dydrogesterone during the first trimester will reduce the incidence of gestational hypertension in primigravidae. Gynecol Endocrinol. 2014;30(3):217–220.
   PubMed Web of Science ®Google Scholar
• Mohamad Razi ZR, Schindler AE. Review on role of progestogen (dydrogesterone) in the prevention of gestational hypertension. Horm Mol Biol Clin Investig. 2016;27(2):73–76.
   PubMed Web of Science ®Google Scholar
• Hitti J, Sienas L, Walker S, et al. Contribution of hypertension to severe maternal morbidity. Am J Obstet Gynecol. 2018;219(4):405.e1–405.e7.
   Web of Science ®Google Scholar
• Wisner K. Gestational hypertension and preeclampsia. MCN Am J Matern Child Nurs. 2019;44(3):170.
   PubMed Web of Science ®Google Scholar
• Bharti J, Vatsa R, Singhal S, et al. Pregnancy with chronic kidney disease: maternal and fetal outcome. Eur J Obstet Gynecol Reprod Biol. 2016;204:83–87.
   PubMed Web of Science ®Google Scholar
• Bramham K, Seed PT, Lightstone L, et al. Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int. 2016;89(4):874–885.
   PubMed Web of Science ®Google Scholar
• Olson KN, Redman LM, Sones JL. Obesity “complements” preeclampsia. Physiol Genomics. 2019;51(3):73–76.
   PubMed Web of Science ®Google Scholar
• Lopez-Jaramillo P, Barajas J, Rueda-Quijano SM, et al. Obesity and preeclampsia: common pathophysiological mechanisms. Front Physiol. 2018;9:1838.
   PubMed Web of Science ®Google Scholar
• Fernández Alba JJ, Mesa Páez C, Vilar Sánchez Á, et al. Overweight and obesity at risk factors for hypertensive states of pregnancy: a retrospective cohort study. Nutr Hosp. 2018;35(4):874–880.
   PubMed Web of Science ®Google Scholar
• Skråstad RB, Hov GG, Blaas HG, et al. A prospective study of screening for hypertensive disorders of pregnancy at 11–13 weeks in a Scandinavian population. Acta Obstet Gynecol Scand. 2014;93(12):1238–1247.
   PubMed Web of Science ®Google Scholar
• Košir Pogačnik R, Trojner Bregar A, Lučovnik M, et al. The effect of interaction between parity, gestational diabetes, and pregravid obesity on the incidence of preeclampsia. J Matern Fetal Neonatal Med. 2018;1–4.
   PubMed Web of Science ®Google Scholar
• Villa PM, Marttinen P, Gillberg J, et al. Cluster analysis to estimate the risk of preeclampsia in the high-risk prediction and prevention of preeclampsia and intrauterine growth restriction (PREDO) study. PLoS One. 2017;12(3):e0174399.
   PubMed Web of Science ®Google Scholar
• Bernardes TP, Mol BW, Ravelli ACJ, et al. Recurrence risk of preeclampsia in a linked population-based cohort: effects of first pregnancy maximum diastolic blood pressure and gestational age. Pregnancy Hypertens. 2019;15:32–36.
   PubMed Web of Science ®Google Scholar